The Department of Health – Abu Dhabi (DoH) has launched a groundbreaking Declaration on Longevity and Precision Medicine at Abu Dhabi Global Health Week 2025, marking a milestone in efforts to transform healthcare delivery and research worldwide.
As the first initiative of its kind, and developed in collaboration with leading international health organisations, academic institutions, and industry pioneers, the declaration establishes key principles to accelerate the advancement of precision medicine and longevity science.
The signing was led by DoH and included M42, Masdar City, PureHealth, Illumina, NYU Abu Dhabi, the University of Pennsylvania, Aldar, Children’s National Hospital, Burjeel, the Children’s Hospital of Philadelphia, and the Institute for Healthier Living Abu Dhabi (IHLAD).
His Excellency Mansoor Ibrahim Al Mansoori, Chairman of DoH, said: “Healthy populations lead to healthy communities, stronger social cohesion, and fuel economic growth. This declaration unites global leaders to harness emerging technologies responsibly and deliver the benefits of precision medicine to all. Because health knows no boundaries, we are working together towards actionable and long-term solutions.”
Developed in collaboration with experts worldwide, the declaration aims to drive the adoption of personalised care and promote research into extending healthy lifespans. It highlights the urgency of addressing the widening healthspan-lifespan gap, which currently stands at nearly a decade globally.
The declaration comes at a critical time as the World Health Organization projects the global population aged 60 and older will double to 2.1 billion by 2050. Concurrently, the precision medicine market is expected to grow from US$81 billion in 2023 to more than US$175 billion by 2030.
The United Arab Emirates is a regional and global leader in the longevity market, driven by pioneering regulatory frameworks, investments in precision medicine, and groundbreaking initiatives, such as the world’s first licensed Healthy Longevity Medicine Centre. The UAE's longevity market is estimated to reach US$32 billion by 2026, up from US$19 billion in 2020.
The declaration outlines bold commitments to advance longevity science, artificial intelligence, diagnostics, and personalised therapeutics. It sets forth six key pillars: advancing research and innovation, enhancing collaboration and knowledge-sharing, investing in education and workforce development, advocating for supportive policy and regulation, upholding ethics and responsible practices, and engaging the public about longevity research and its implications for health and society.
PwC Middle East, a strategic partner in the initiative, highlighted the global significance of the declaration in advancing global healthcare priorities.
Lina Shadid, Health Industries Leader, PwC Middle East, said: "The declaration on longevity and precision medicine provides a global blueprint for integrating AI, genomics, and precision healthcare into mainstream medical practice and within the health ecosystem, to accelerate the adoption of life-changing medical innovations worldwide.
“The declaration reflects Abu Dhabi’s ongoing commitment to shaping the future of health through knowledge-sharing, investment in research, and the integration of emerging technologies. By convening global experts and institutions, DoH is ushering in a new era of precision medicine —one that prioritises personalised and preventative care, and enhances quality of life for populations worldwide.”
Governments, health organisations and relevant stakeholders worldwide are encouraged to sign the declaration.
ADGHW 2025 is a major government initiative from DoH and serves as a platform for innovation and collaboration under the theme Towards Longevity: Redefining Health and Well-being. It places a strong emphasis on community-driven health and wellbeing, with a proactive approach centred around preventive, personalised, and holistic care.
